source
- DSV A/S reports manager share transactions in latest company announcementDSV A/S issued Company Announcement No. 1171, informing the market of recent share transactions carried out by a company manager. The disclosure is made under Article 19 of EU Regulation 596/2014,…
- Eli Lilly to seek FDA approval for retatrutide in early 2027 after Phase 3 trials show over 20% weight lossEli Lilly said its next‑generation obesity drug retatrutide produced substantial weight loss in two late‑stage Phase 3 studies. The data were presented from the TRIUMPH‑2 and TRIUMPH‑3 trials, whic…